Because the CONCERTA tablet is nondeformable and does not appreciably improve in form during the GI tract, CONCERTA should not ordinarily be administered to patients with preexisting serious gastrointestinal narrowing (pathologic or iatrogenic, one example is: esophageal motility disorders, modest bowel inflammatory sickness, "quick intestine" synd